Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If this continues down into the 20’s we are tripling down, free shares anyway since the big explosion to 50’s
We shorted the offering for 2 days, in an out then long since
That was way back, we went long but are out. Missed this pop
Did you SHORT CLDX back in NOV 2023?
If you did you loss your PANTS (SHORTS)
Burn cldx burn, another round of dilution, shorting this is money!
Sold out the pump thank god. Short position now after this news of dilution, this company sure knows how to screw long investors. 25k short, lets take it to 20 now folks
Told everybody shorts are an still are in deep risk moving forward. Looking at a run to 44+ coming
Cldx will be bought out in due time imo $$$$$$$$ shorts continue to burn to ground
Burn shorts burn, this is going to be epic when it happens, buyout can happen anytime! $$$$$
I can’t wait to see the naked shorts fry like pigs when the buyout price is announced!40+ $$$$$!
Buy it up shorts are gonna pay deeply, buyout ahead imo. $$$$$$
Buying opportunity, bought the dip at open, looking real good
Could be a buyout coming
This stock use to be called Avant Immunotherapeutics
Avant Immunotherapeutics to Merge with Celldex Therapeutics, Inc. in All-Stock Deal
Hey mr canes, how u been, gl this year
More wealth with this play, question is, what is brewing here, not many followers but flipping this has been easy money, all free shares here riding it onward for some epic news
Lmao, your alright. GL
Based on your imbecilic remarks I implore you seek counseling. Pointedly seek juvenile counseling. Now please go back to posting to yourself. I'm taking to my wife out to our favorite Michelin spot and a enjoying bottle of Dom Perignon. The 2003 Plenitude - 2 is special. Of course since you can't afford it you'll have to take my word for it. Have a cold Busch instead it's as close as you'll come to a woman. Get well!
Dont forget to put your dolls away, barbie might get mad at you.
Yur wife luvs me! Lmao little guy
You're making me laugh...you made my morning! By the way I bought Celldex way before you and your fantasy group. Go back to posting gibberish with someone else. I'm busy raking in money shorting your minuscule positions. You're the king...of clowns on IHUB.
Yo brainless, if you would hav bought this when we did in the 20’s you would be thanking me like the rest of my group is now, a true double so go get lost under a rock an learn how to invest an become a real investor like i am. You will never het rich pal, lmao
Is there anyone else into cldx on here, what a run in last 3 weeks!$$$$
Nobody here? This just keeps popping
A whale knows when a bio is on to something, cldx may finally hit it big! $$$
More good news an the stock gets hammered. Typical bio shorting. Could be a 100+ pps one day!
Whats the word on this freefall going on? Just shorts trying to leverage more out of it before it goes to 50+, word on the vine is they may have a huge winner coming
Something is going to be announced real soon, an its looking positive imo! $$$$
Don't forget the additional $26,500,000 million they can add.
Another $175,000,000 raised in dilution... Share price depletes
W.e. let one switch how they want, if something failed. I'd flip side as well lmao
Get lost, you got no clue who we are, lmao. If u did u would want in with us, trust me. We run stocks an avoid people like u
Crumb showed up on IDRA years ago. He was pounding the table for months telling everybody to buy it. He touted their amazing pipeline. Then they failed a Phase 3. The very next day he was short and said he had warned everyone to steer clear of the POS. He isn't a legitimate investor. If he was he wouldn't be killing time posting almost 10,000 times on IHUB. Legitimate investors invest they don't incessantly post rubbish.
Can trade in any direction and get burnt in any direction. Everyone trades differently.
Def make some either way you trade but the financials and beyond that. It's only going to get worse. It's only Phase 1b... Many phases to go 2 & 3 (a +b maybe)doubles time and phases again. That's only the phases with out going into specifics.
I have a great track record. I do the opposite of what you profess to be doing and it's been 100% successful LMAO!
Lmao, someday you might learn how to trade, GL
Followers
|
90
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1911
|
Created
|
05/29/02
|
Type
|
Free
|
Moderators |
Celldex Therapeutics, Inc. (CLDX)
http://www.celldextherapeutics.com
Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax: 908-454-1911
CIK
0000744218
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
Management:
http://www.celldextherapeutics.com/about/management.php
Product Pipeline:
http://www.celldextherapeutics.com/pipeline/pipeline-overview.php
News and Press Releases:
http://ir.celldextherapeutics.com/releases.cfm
http://finance.yahoo.com/q/h?s=CLDX+Headlines
http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
Events and Presentations:
http://ir.celldextherapeutics.com/events.cfm
SEC Filings:
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000744218&owner=exclude&count=40
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
Share Structure:
See SEC filings
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications
ir@celldextherapeutics.com
----------------------------------------------
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |